BridgeMD
New treatment option for Breast Cancer
Official title Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients
ClinicalTrials.gov ID: NCT07273812
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if an Arabic-language mobile application that uses artificial intelligence (AI) can help women with breast cancer during chemotherapy. The app is designed to give personalized support by reminding participants about their medications, teaching them how to manage treatment side effects, and alerting their healthcare team about serious symptoms.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Confirmed diagnosis of breast cancer stages I, II, or III.
- Patients must be currently scheduled to initiate their first-ever cycle of chemotherapy.
- Age 18 years or older.
- Ability to understand and provide informed consent.
- Possession of a smartphone (Android or iOS) and functional digital literacy, defined as the ability to independently navigate mobile applications...
You likely can't join if
- Patients with Stage IV (Metastatic) breast cancer.
- Patients receiving concurrent hormonal therapy during the chemotherapy phase, to isolate chemotherapy-induced adverse events. Patients with cognitive...
- Patients receiving palliative care where symptom management is the sole focus and active chemotherapy is not being administered with curative or life...
- Patients participating in other treatment clinical trials that might confound the outcomes of this study.
- Patients with severe comorbidities that could significantly impact their ability to participate or bias outcome measures.
See the full eligibility criteria
- Confirmed diagnosis of breast cancer stages I, II, or III.
- Patients must be currently scheduled to initiate their first-ever cycle of chemotherapy.
- Age 18 years or older.
- Ability to understand and provide informed consent.
- Possession of a smartphone (Android or iOS) and functional digital literacy, defined as the ability to independently navigate mobile applications, read on-screen text in Arabic, and input daily health data. (for the...
- Willingness to comply with study procedures and follow-up schedules.
- Ability to communicate in Arabic, as the mobile application and chatbot will be developed in Arabic.
- Patients with Stage IV (Metastatic) breast cancer.
- Patients receiving concurrent hormonal therapy during the chemotherapy phase, to isolate chemotherapy-induced adverse events. Patients with cognitive impairment or severe psychiatric disorders that would preclude...
- Patients receiving palliative care where symptom management is the sole focus and active chemotherapy is not being administered with curative or life prolonging intent.
- Patients participating in other treatment clinical trials that might confound the outcomes of this study.
- Patients with severe comorbidities that could significantly impact their ability to participate or bias outcome measures.
The study team makes the final eligibility decision.
Where it's taking place
- Baghdad, Iraq
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baghdad, Iraq. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.